UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Short-term chloral hydrate as an add-on treatment may improve sleep and alleviate agitation in inpatients with treatment resistant schizophrenia: a retrospective case series study

Frontiers in psychiatry, 2024-02, Vol.15, p.1293676-1293676

2024

Volltextzugriff (PDF)

Beliefs and emotional reactions in patients with benign paroxysmal positional vertigo: a longitudinal study

American journal of otolaryngology, 2012-03, Vol.33 (2), p.221-225

2012

Volltextzugriff (PDF)

Amantadine as augmentation therapy in the management of treatment-resistant depression

International clinical psychopharmacology, 2003-03, Vol.18 (2), p.93-96

2003

Volltextzugriff (PDF)

A Double-Blind, Placebo-Controlled Trial of Bupropion Add-on to Olanzapine or Risperidone in Overweight Individuals With Schizophrenia

Journal of clinical psychopharmacology, 2021-11, Vol.41 (6), p.629-631

2021

Volltextzugriff (PDF)

Fatigue during an episode of benign paroxysmal positional vertigo

European archives of oto-rhino-laryngology, 2015-09, Vol.272 (9), p.2129-2133

2015

Volltextzugriff (PDF)

Alterations in plasma endocannabinoid concentrations among individuals with major depression treated with electroconvulsive therapy

Psychiatry research, 2024-07, Vol.337, p.115967-115967, Article 115967

2024

Volltextzugriff (PDF)

Add-on benzodiazepines for psychosis-induced aggression

International clinical psychopharmacology, 2019-05, Vol.34 (3), p.119-123

2019

Volltextzugriff (PDF)

Equine Assisted Therapy for Patients with Post Traumatic Stress Disorder: A Case Series Study

Military medicine, 2019-10, Vol.184 (9-10), p.394-399

2019

Volltextzugriff (PDF)

Olanzapine intramuscular shows better efficacy than zuclopenthixol acetate intramuscular in reducing the need for restraint, but not in comparison to haloperidol intramuscular

International clinical psychopharmacology, 2022-01, Vol.37 (1), p.9-13

2022

Volltextzugriff (PDF)

Inflammation Markers Among Schizophrenia Patients Who Use Cannabis

Clinical neuropharmacology, 2023-07, Vol.46 (4), p.145-148

2023

Volltextzugriff (PDF)

Approach to bilateral benign paroxysmal positioning vertigo

American journal of otolaryngology, 2006-03, Vol.27 (2), p.91-95

2006

Volltextzugriff (PDF)

The effectiveness of high-dose escitalopram in the treatment of patients suffering from schizophrenia with comorbid obsessive-compulsive disorder: an open-label study

International clinical psychopharmacology, 2019-07, Vol.34 (4), p.179-183

2019

Volltextzugriff (PDF)

Polymorphism Screening of PIP5K2A: A Candidate Gene for Chromosome 10p-Linked Psychiatric Disorders

American journal of medical genetics. Part B, Neuropsychiatric genetics, 2003-11, Vol.123B (1), p.50-58

2003

Volltextzugriff (PDF)

Cognitive enhancement drug use among resident physicians: Prevalence and motivations for use - results from a survey

Journal of addictive diseases, 2020-04, Vol.38 (3), p.250-256

2020

Volltextzugriff (PDF)

Cognitive enhancement drug use among resident physicians: Prevalence and motivations for use - results from a survey

Journal of addictive diseases, 2020-04, Vol.38 (3), p.250-256

2020

Volltextzugriff (PDF)

Amantadine augmentation therapy for obsessive compulsive patients resistant to SSRIs-an open-label study

Clinical neuropharmacology, 2014-05, Vol.37 (3), p.79-81

2014

Volltextzugriff (PDF)

Escitalopram in the treatment of patients with schizophrenia and obsessive-compulsive disorder: an open-label, prospective study

International clinical psychopharmacology, 2013-03, Vol.28 (2), p.96-98

2013

Volltextzugriff (PDF)

Magnetic resonance brain imaging in patients with visual vertigo

Brain and behavior, 2015-11, Vol.5 (11), p.e00402-n/a

2015

Volltextzugriff (PDF)

Mianserin for the rapid improvement of chronic akathisia in a schizophrenia patient

European psychiatry, 2004-06, Vol.19 (4), p.237-238

2004

Volltextzugriff (PDF)

Analysis of clinical symptomatology, extrapyramidal symptoms and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in olanzapine treated schizophrenia patients: A randomized, double-blind placebo controlled trial

Psychoneuroendocrinology, 2007-02, Vol.32 (2), p.96-105

2007

Volltextzugriff (PDF)

Rivastigmine treatment for the prevention of electroconvulsive therapy-induced memory deficits in patients with schizophrenia

Clinical neuropharmacology, 2012-07, Vol.35 (4), p.161-164

2012

Volltextzugriff (PDF)

Trazodone for the treatment of neuroleptic-induced acute akathisia: a placebo-controlled, double-blind, crossover study

Clinical neuropharmacology, 2010-09, Vol.33 (5), p.219-222

2010

Volltextzugriff (PDF)

NEUROPSYCHIATRIC MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS

הרפואה, 2017-12, Vol.156 (12), p.779

2017

Volltextzugriff (PDF)

Beta-adrenergic antagonists for the treatment of clozapine-induced sinus tachycardia: a retrospective study

Clinical neuropharmacology, 2009-09, Vol.32 (5), p.290-292

2009

Volltextzugriff (PDF)

Social Anxiety Disorder Comorbid with Schizophrenia: The Importance of Screening for This Under recognized and Under treated Condition

Israel journal of psychiatry and related sciences, 2015, Vol.52 (1), p.40

2015

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(50)

Sprache

Englisch
(49)
Hebräisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(44)
Science & Technology
(44)
Humans
(42)
Female
(35)
Male
(34)
Adult
(32)
Middle Aged
(32)
Psychiatry
(27)
Pharmacology & Pharmacy
(23)
Neurosciences & Neurology
(22)
Clinical Neurology
(19)
Schizophrenia
(16)
Schizophrenia - Drug Therapy
(14)
Psychiatric Status Rating Scales
(13)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Antipsychotic Agents - Therapeutic Use
(11)
Neurosciences
(11)
Aged
(10)
Treatment Outcome
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Short-term chloral hydrate as an add-on treatment may improve sleep and alleviate agitation in inpatients with treatment resistant schizophrenia: a retrospective case series study

Beliefs and emotional reactions in patients with benign paroxysmal positional vertigo: a longitudinal study

Amantadine as augmentation therapy in the management of treatment-resistant depression

A Double-Blind, Placebo-Controlled Trial of Bupropion Add-on to Olanzapine or Risperidone in Overweight Individuals With Schizophrenia

Fatigue during an episode of benign paroxysmal positional vertigo

Alterations in plasma endocannabinoid concentrations among individuals with major depression treated with electroconvulsive therapy

Add-on benzodiazepines for psychosis-induced aggression

Equine Assisted Therapy for Patients with Post Traumatic Stress Disorder: A Case Series Study

Olanzapine intramuscular shows better efficacy than zuclopenthixol acetate intramuscular in reducing the need for restraint, but not in comparison to haloperidol intramuscular

Inflammation Markers Among Schizophrenia Patients Who Use Cannabis

Approach to bilateral benign paroxysmal positioning vertigo

The effectiveness of high-dose escitalopram in the treatment of patients suffering from schizophrenia with comorbid obsessive-compulsive disorder: an open-label study

Polymorphism Screening of PIP5K2A: A Candidate Gene for Chromosome 10p-Linked Psychiatric Disorders

Cognitive enhancement drug use among resident physicians: Prevalence and motivations for use - results from a survey

Cognitive enhancement drug use among resident physicians: Prevalence and motivations for use - results from a survey

Amantadine augmentation therapy for obsessive compulsive patients resistant to SSRIs-an open-label study

Escitalopram in the treatment of patients with schizophrenia and obsessive-compulsive disorder: an open-label, prospective study

Magnetic resonance brain imaging in patients with visual vertigo

Mianserin for the rapid improvement of chronic akathisia in a schizophrenia patient

Analysis of clinical symptomatology, extrapyramidal symptoms and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in olanzapine treated schizophrenia patients: A randomized, double-blind placebo controlled trial

Rivastigmine treatment for the prevention of electroconvulsive therapy-induced memory deficits in patients with schizophrenia

Trazodone for the treatment of neuroleptic-induced acute akathisia: a placebo-controlled, double-blind, crossover study

NEUROPSYCHIATRIC MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS

Beta-adrenergic antagonists for the treatment of clozapine-induced sinus tachycardia: a retrospective study

Social Anxiety Disorder Comorbid with Schizophrenia: The Importance of Screening for This Under recognized and Under treated Condition

Suchergebnisse filtern